ArticleNature medicine2024
Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Nabil F Saba et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it